Literature DB >> 8499330

Detection of aromatase and keratinocyte growth factor expression in breast tumors using reverse transcription-polymerase chain reaction.

R D Koos1, P K Banks, S E Inkster, W Yue, A M Brodie.   

Abstract

It has been proposed that local production of estrogen may contribute to breast tumor growth, in part by regulating growth factor production. In view of this, we studied the expression of mRNAs for aromatase cytochrome P-450, the enzyme which catalyzes estrogen synthesis, and keratinocyte growth factor (KGF), a heparin-binding growth factor specific for epithelial cells, in breast tumors. In order to detect mRNAs of low-abundance, reverse transcription-polymerase chain reaction (RT-PCR) was used. RNA from breast tumors and normal breast tissue was reverse transcribed and then amplified using oligonucleotide primers for human aromatase or KGF. Twelve of 15 breast tumor samples yielded variable amounts of aromatase PCR product, but consistently strong KGF PCR signals. Of the three aromatase mRNA-negative samples, two gave weak KGF signals while one was negative for KGF. Both aromatase and KGF transcripts were also detected in all five normal breast tissue samples examined. These results indicate that a high proportion of breast tumors have the potential to produce aromatase and KGF, both of which could play important roles in their growth. The results also suggest that RT-PCR can be used to evaluate local expression of growth mediators in tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499330     DOI: 10.1016/0960-0760(93)90335-t

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  10 in total

Review 1.  Regulation of mammary gland growth and morphogenesis by the mammary fat pad: a species comparison.

Authors:  R C Hovey; T B McFadden; R M Akers
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

2.  Keratinocyte growth factor-induced motility of breast cancer cells.

Authors:  X P Zang; J T Pento
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Detection of keratinocyte growth factor (KGF) messenger ribonucleic acid and immunolocalization of KGF in the canine testis.

Authors:  W Y Chang; S K Kulp; Y Sugimoto; H Canatan; F Shidaifat; N Inpanbutr; Y C Lin
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

4.  KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2.

Authors:  Xiao-Ping Zang; Doris R Siwak; Thi X Nguyen; Ana M Tari; J Thomas Pento
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 5.  Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.

Authors:  V C Njar; A M Brodie
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

6.  Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor.

Authors:  T R Ulich; E S Yi; R Cardiff; S Yin; N Bikhazi; R Biltz; C F Morris; G F Pierce
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

Review 7.  Regulation of aromatase expression in human tissues.

Authors:  S E Bulun; E R Simpson
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Starfish polysaccharides downregulate metastatic activity through the MAPK signaling pathway in MCF-7 human breast cancer cells.

Authors:  Kyu-Shik Lee; Jin-Sun Shin; Kyung-Soo Nam
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

Review 9.  The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer.

Authors:  Angela Brodie; Vincent Njar; Luciana Furtado Macedo; T Sean Vasaitis; Gauri Sabnis
Journal:  Urol Oncol       Date:  2009 Jan-Feb       Impact factor: 3.498

10.  Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cells.

Authors:  Sabrina Rotolo; Simona Ceccarelli; Ferdinando Romano; Luigi Frati; Cinzia Marchese; Antonio Angeloni
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.